Zest has unveiled a new app-based cognitive test designed to screen for the early signs of dementia, as efforts ramp up in ...

Finland’s University of Turku researchers have developed a fluorescent probe for visualising the signalling dynamics in ...

Brain-computer interface (BCI) technologies are advancing rapidly, and – as with other innovations like artificial ...

With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA ...

GE HealthCare and PT Kalbe Farma Tbk (Kalbe) have launched the first computed tomography (CT) scanner production facility in ...

Neuralink has secured $650m in a Series E financing round, marking a milestone in the advancement of its brain implant ...

Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System ...

A new EU consortium has launched with the aim to reduce pancreatic cancer mortality rate across the continent.

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...